http://www.unboundmedicine.com/medline/ebm/research/warfarinUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19892427/full_citation/Design_evaluation_and_optimisation_in_multiple_response_nonlinear_mixed_effect_models:_PFIM_3_0_Bazzoli C, Retout S, Mentré F 
Design evaluation and optimisation in multiple response nonlinear mixed effect models: PFIM 3.0. [JOURNAL ARTICLE]
Comput Methods Programs Biomed 2009 Nov 3.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19892063/full_citation/Comparison_of_safety_of_subcutaneous_enoxaparin_as_outpatient_anticoagulation_bridging_therapy_in_patients_with_a_mechanical_heart_valve_versus_patients_with_nonvalvular_atrial_fibrillation_Bui HT, Krisnaswami A, Le CU, et al. 
Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation. [Journal Article]
Am J Cardiol 2009 Nov 15; 104(10):1429-33.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19891559/full_citation/Survey_on_warfarin_pharmacogenetic_testing_among_anticoagulation_providers_Kadafour M, Haugh R, Posin M, et al. 
Survey on warfarin pharmacogenetic testing among anticoagulation providers. [Journal Article]
Pharmacogenomics 2009 Nov; 10(11):1853-60.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19891071/full_citation/HOTLINE_I_RE_LY_diabigatran_gains_ground_on_warfarin_HOTLINE I, RE-LY, diabigatran gains ground on warfarin. [Journal Article]
Eur Heart J 2009 Nov; 30(21):2542.
Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19888552/full_citation/New_oral_anticoagulants:_a_practical_guide_for_clinicians_Wittkowsky AK 
New oral anticoagulants: a practical guide for clinicians. [JOURNAL ARTICLE]
J Thromb Thrombolysis 2009 Nov 4.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19884975/full_citation/A_cardiovascular_phenotype_in_warfarin_resistant_Vkorc1_mutant_rats_Kohn MH, Price RE, Pelz HJ 
A cardiovascular phenotype in warfarin-resistant Vkorc1 mutant rats. [JOURNAL ARTICLE]
Artery Res 2008 Nov; 2(4):138-147.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19883802/full_citation/Surgical_work_load_risk_factors_and_complications_in_patients_on_warfarin_with_gastrointestinal_bleeding_Som R, Gossage JA, Crane A, et al. 
Surgical work load, risk factors and complications in patients on warfarin with gastrointestinal bleeding. [JOURNAL ARTICLE]
Int J Surg 2009 Oct 30.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19883336/full_citation/Skin_autoimmunity_and_blood_coagulation_Cugno M, Tedeschi A, Asero R, et al. 
Skin autoimmunity and blood coagulation. [JOURNAL ARTICLE]
Autoimmunity 2009 Nov 3.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19882303/full_citation/Warfarin_anticoagulation_reversal:_management_of_the_asymptomatic_and_bleeding_patient_Makris M, van Veen JJ, Maclean R 
Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient. [JOURNAL ARTICLE]
J Thromb Thrombolysis 2009 Nov 1.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19881396/full_citation/Pharmacogenomic_trial_design:_use_of_a_PK/PD_model_to_explore_warfarin_dosing_interventions_through_clinical_trial_simulation_Salinger DH, Shen DD, Thummel K, et al. 
Pharmacogenomic trial design: use of a PK/PD model to explore warfarin dosing interventions through clinical trial simulation. [JOURNAL ARTICLE]
Pharmacogenet Genomics 2009 Oct 29.
Abstract | Full Citation | Find Related Articles